ADOR Diagnostics is a series a startup. 1 investor tracked.
ADOR Diagnostics is a company headquartered in Italy. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
ADOR Diagnostics develops advanced molecular diagnostics through its NATlab platform, offering rapid and accurate detection of infectious diseases using multiplex syndromic testing.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.